BCHE and Alzheimer disease: Importantly, clinical studies support beneficial effects of cholinesterase inhibitor treatment in both PD and AD patients (Emre et al., 2004; Zhu et al., 2013), suggesting a need to better understand how cholinergic neuron dysfunction contributes to symptoms in PD, AD, and other NDDs.